Exosomes Derived from BMMSCs Mitigate the Hepatic Fibrosis via Anti-Pyroptosis Pathway in a Cirrhosis Model

Exosomes Derived from BMMSCs Mitigate the Hepatic Fibrosis via Anti-Pyroptosis Pathway in a Cirrhosis Model

Researchers increasingly report the therapeutic effect of exosomes derived from rat bone marrow mesenchymal stem cells (Exos-rBMMSC) on liver disease, while the optimal dose of Exos-rBMMSC in liver cirrhotic treatment has not been reported. In this study, we aimed to explore the efficacy and dose of...

Full description

Bibliographic Details
Main Authors: Yichi Zhang, Hanjing Zhangdi, Xinsheng Nie, Lijuan Wang, Zhuzhi Wan, Hao Jin, Ronghui Pu, Meihui Liang, Yuan Chang, Yang Gao, Hailong Zhang, Shizhu Jin
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Exo-rBMMSC
BMMSCs
liver cirrhosis
pyroptosis
Online Access:https://www.mdpi.com/2073-4409/11/24/4004

Internet

https://www.mdpi.com/2073-4409/11/24/4004

Similar Items